129 related articles for article (PubMed ID: 16858234)
21. Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure.
McDowell G; Gupta S; Dellerba M; Coppinger T; Levy RD; Keevil BG
Ann Clin Biochem; 2004 Nov; 41(Pt 6):491-3. PubMed ID: 15588442
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
23. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
[TBL] [Abstract][Full Text] [Related]
24. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
[TBL] [Abstract][Full Text] [Related]
25. [Cardiac natriuretic peptides in heart failure].
Cvorisćec D; Cepelak I
Lijec Vjesn; 2006; 128(9-10):279-85. PubMed ID: 17128666
[TBL] [Abstract][Full Text] [Related]
26. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
[TBL] [Abstract][Full Text] [Related]
27. B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger?
Rutten FH; Hoes AW
Int J Cardiol; 2008 Apr; 125(2):161-5. PubMed ID: 17963872
[TBL] [Abstract][Full Text] [Related]
28. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
[No Abstract] [Full Text] [Related]
29. Diagnostic markers for early detection of ovarian cancer.
Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of Ca 125 levels during primary therapy.
Markmann S; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
[TBL] [Abstract][Full Text] [Related]
31. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
Hradec J; Krupicka J; Janota T
Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in heart failure management.
Isaac DL
Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
[TBL] [Abstract][Full Text] [Related]
33. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy.
Cecchi E; Lapi F; Vannacci A; Banchelli G; Mazzei T; Mugelli A
J Clin Pharm Ther; 2009 Feb; 34(1):129-32. PubMed ID: 19125912
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
36. [The role of natriuretic peptides in heart failure].
Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
[TBL] [Abstract][Full Text] [Related]
37. A concise review of serum markers for hepatocellular cancer.
Wright LM; Kreikemeier JT; Fimmel CJ
Cancer Detect Prev; 2007; 31(1):35-44. PubMed ID: 17293059
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
Christoforidis A; Lefkou E; Vlachaki E; Perifanis V; Tsatra I; Dogramatzi F; Athanassiou-Metaxa M
Ann Hematol; 2007 Nov; 86(11):837-41. PubMed ID: 17668208
[TBL] [Abstract][Full Text] [Related]
39. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
40. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
Oremek G; Sauer-Eppel H; Klepzig M
Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
